US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

108.40

+0.80000.74%

Post-market: 108.400.0025+0.00%16:28 EDT

Volume:1.30M

Turnover:141.34M

Market Cap:4.93B

PE:52.88

High:110.45

Open:108.95

Low:107.60

Close:107.60

52wk High:110.45

52wk Low:47.32

Shares:45.45M

Float Shares:44.60M

Volume Ratio:2.22

T/O Rate:2.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.05

EPS(LYR):2.05

ROE:11.20%

ROA:6.60%

PB:5.89

PE(LYR):52.88

Loading ...

Overview Company News Filings

Haemonetics study shows VASCADE MVP XL outperforms VASCADE MVP in large-bore venous closure

GVS FY25 net profit drops to EUR 18.4 million; revenue slips to EUR 424.7 million

Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference

Pharvaris: Deucrictibant Data, Strengthened HAE Pipeline, and Extended Cash Runway Support Higher $52 DCF-Based Target and Buy Rating

BTIG Reaffirms Their Buy Rating on Haemonetics (HAE)

Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors

Haemonetics price target lowered to $64 from $70 at Citi

Orchestra BioMed presentation highlights pivotal trials for hypertension pacing, sirolimus artery therapy

Does CHAPTER-3 Enrollment Milestone and Pipeline Progress Change The Bull Case For Pharvaris (PHVS)?

Simply Wall St.

Press Release: Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Haemonetics sets earnings release, conference call for fiscal Q4, full-year results

Haemonetics wins FDA label expansion for VASCADE MVP XL venous closure system

Haemonetics Receives FDA Approval for Expanded Labeling of the Vascade Mvp® Xl Venous Vascular Closure System

THOMSON REUTERS

A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness

Simply Wall St.

Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista

Italy's GVS FY revenue rises on healthcare & life sciences strength

Here's one reason why experts think the CSL share price can rise 65%!

Press Release: KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/HAE/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"HAE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","market":"US","secType":"STK","nameCN":"Haemonetics","latestPrice":108.4,"timestamp":1789761600000,"preClose":107.6,"halted":0,"volume":1300441,"hourTrading":{"tag":"盘后","latestPrice":108.4025,"preClose":108.4,"latestTime":"16:28 EDT","volume":157484,"amount":17071278.98614,"timestamp":1789763312237,"change":0.0025,"changeRate":0.000023,"amplitude":0.000557},"delay":0,"changeRate":0.007434944237918322,"floatShares":44597205,"shares":45446000,"eps":2.05,"marketStatus":"Post-Mkt","change":0.8,"latestTime":"09-18 17:55:25 EDT","open":108.95,"high":110.45,"low":107.6,"amount":141343299,"amplitude":0.026487,"askPrice":114.42,"askSize":32,"bidPrice":92.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.05,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":673761600000,"exchange":"NYSE","adjPreClose":107.6,"preHourTrading":{"tag":"盘前","latestPrice":109,"preClose":107.6,"latestTime":"08:56 EDT","volume":303,"amount":32647.540979999998,"timestamp":1789736166307,"change":1.4,"changeRate":0.013011,"amplitude":0.060409},"postHourTrading":{"tag":"盘后","latestPrice":108.4025,"preClose":108.4,"latestTime":"16:28 EDT","volume":157484,"amount":17071278.98614,"timestamp":1789763312237,"change":0.0025,"changeRate":0.000023,"amplitude":0.000557},"volumeRatio":2.220607,"impliedVol":0.4056,"impliedVolPercentile":0.2789},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HAE\",,,,,undefined,":{"symbol":"HAE","floatShares":44597205,"roa":"6.60%","roe":"11.20%","lyrEps":2.05,"volumeRatio":2.220607,"shares":45446000,"dividePrice":0,"high":110.45,"amplitude":0.026487,"preClose":107.6,"low":107.6,"week52Low":47.315,"pbRate":"5.89","psRate":"3.64","week52High":110.45,"institutionHeld":0.8352,"latestPrice":108.4,"committee":0.515152,"eps":2.05,"divideRate":0,"volume":1300441,"delay":0,"ttmEps":2.05,"open":108.95,"prevYearClose":80.15,"prevWeekClose":102.69,"prevMonthClose":103.07,"prevQuarterClose":75,"fiveDayClose":102.69,"twentyDayClose":108.22,"sixtyDayClose":72.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HAE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"HAE","fiscalQuarterEnding":"2026/06","expectedEps":1.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":1.14},{"market":"US","date":"2026-05-07","symbol":"HAE","fiscalQuarterEnding":"2026/03","expectedEps":1.28,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":1.29},{"market":"US","date":"2026-02-05","symbol":"HAE","fiscalQuarterEnding":"2025/12","expectedEps":1.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770267600000,"reportTimeType":"pre","actualEps":1.19},{"market":"US","date":"2025-11-06","symbol":"HAE","fiscalQuarterEnding":"2025/09","expectedEps":1.12,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":1.27},{"market":"US","date":"2025-08-07","symbol":"HAE","fiscalQuarterEnding":"2025/06","expectedEps":1.01,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":1.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HAE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HAE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.3636,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1789704000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HAE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HAE","date":"2026-09-17","current":52.878049,"percent":0.749796,"low":13.951789,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"high":144.446304,"avg":43.336269,"sd":26.87896,"marketCap":4833606698},"quantilePoints":[{"date":"2021-09-24","current":54.916965,"twenty":-35.993895,"median":63.068193,"eighty":109.700335,"marketCap":3541485232},{"date":"2021-10-01","current":56.900582,"twenty":-35.993895,"median":62.475524,"eighty":109.700335,"marketCap":3669404760},{"date":"2021-10-08","current":53.344296,"twenty":-35.993895,"median":61.853028,"eighty":109.700335,"marketCap":3440066962},{"date":"2021-10-15","current":55.248885,"twenty":-35.993895,"median":61.375039,"eighty":109.700335,"marketCap":3562890094},{"date":"2021-10-22","current":56.703011,"twenty":-35.993895,"median":61.047856,"eighty":109.700335,"marketCap":3656663771},{"date":"2021-10-29","current":54.300542,"twenty":-35.993895,"median":60.807745,"eighty":109.700335,"marketCap":3501733348},{"date":"2021-11-05","current":58.947423,"twenty":-35.993895,"median":60.537162,"eighty":109.700335,"marketCap":3801401403},{"date":"2021-11-12","current":98.0786,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":3064269710},{"date":"2021-11-19","current":91.879169,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2870580881},{"date":"2021-11-26","current":84.9273,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2653383645},{"date":"2021-12-03","current":86.317674,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2696823092},{"date":"2021-12-10","current":84.812799,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2649806279},{"date":"2021-12-17","current":86.890181,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2714709923},{"date":"2021-12-23","current":88.591344,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2767859365},{"date":"2021-12-31","current":86.759322,"twenty":-35.993895,"median":60.392328,"eighty":109.700335,"marketCap":2710621505},{"date":"2022-01-07","current":86.088671,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2689668360},{"date":"2022-01-14","current":86.186815,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2692734674},{"date":"2022-01-21","current":80.249102,"twenty":-35.979473,"median":60.499165,"eighty":109.696973,"marketCap":2507222681},{"date":"2022-01-28","current":75.178327,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2348796462},{"date":"2022-02-04","current":76.241554,"twenty":-35.965051,"median":60.537162,"eighty":109.693612,"marketCap":2382014863},{"date":"2022-02-11","current":132.27526,"twenty":-34.668681,"median":60.807745,"eighty":111.039755,"marketCap":2988494959},{"date":"2022-02-18","current":125.601547,"twenty":-34.469979,"median":61.047856,"eighty":111.532645,"marketCap":2837715754},{"date":"2022-02-25","current":129.379548,"twenty":-34.311338,"median":61.359457,"eighty":111.98412,"marketCap":2923072118},{"date":"2022-03-04","current":132.003787,"twenty":-34.051744,"median":61.783676,"eighty":112.835267,"marketCap":2982361568},{"date":"2022-03-11","current":121.778301,"twenty":-33.85785,"median":62.188491,"eighty":113.319081,"marketCap":2751337158},{"date":"2022-03-18","current":129.583152,"twenty":-33.51653,"median":62.994775,"eighty":114.080433,"marketCap":2927672161},{"date":"2022-03-25","current":134.4018,"twenty":-33.327443,"median":63.351243,"eighty":114.297089,"marketCap":3036539858},{"date":"2022-04-01","current":144.446304,"twenty":12.858807,"median":63.591935,"eighty":114.85374,"marketCap":3263475340},{"date":"2022-04-08","current":135.329333,"twenty":26.526131,"median":64.365454,"eighty":118.412035,"marketCap":3057495612},{"date":"2022-04-14","current":128.542506,"twenty":27.793219,"median":64.890745,"eighty":123.456909,"marketCap":2904160827},{"date":"2022-04-22","current":122.185511,"twenty":29.124226,"median":65.319181,"eighty":124.18094,"marketCap":2760537245},{"date":"2022-04-29","current":114.62951,"twenty":31.542784,"median":65.565922,"eighty":124.252941,"marketCap":2589824518},{"date":"2022-05-06","current":117.366864,"twenty":32.033452,"median":67.0792,"eighty":124.252941,"marketCap":2651669548},{"date":"2022-05-13","current":66.271265,"twenty":35.464129,"median":67.3946,"eighty":124.252941,"marketCap":2874516102},{"date":"2022-05-20","current":69.90063,"twenty":36.481486,"median":68.104166,"eighty":124.252941,"marketCap":3031939815},{"date":"2022-05-27","current":75.603918,"twenty":37.198319,"median":69.227072,"eighty":124.252941,"marketCap":3279319935},{"date":"2022-06-03","current":76.004562,"twenty":37.61535,"median":69.681162,"eighty":124.252941,"marketCap":3296697877},{"date":"2022-06-10","current":76.26261,"twenty":38.029161,"median":70.362161,"eighty":124.252941,"marketCap":3307890688},{"date":"2022-06-17","current":71.841246,"twenty":38.485794,"median":71.159351,"eighty":124.252941,"marketCap":3116114046},{"date":"2022-06-24","current":77.149247,"twenty":38.879824,"median":71.841246,"eighty":124.324942,"marketCap":3346348571},{"date":"2022-07-01","current":79.584543,"twenty":39.929153,"median":72.054039,"eighty":124.324942,"marketCap":3451979555},{"date":"2022-07-08","current":78.969808,"twenty":40.349299,"median":72.422071,"eighty":124.324942,"marketCap":3425315423},{"date":"2022-07-15","current":75.798905,"twenty":40.806308,"median":73.633206,"eighty":124.324942,"marketCap":3287777520},{"date":"2022-07-22","current":78.187949,"twenty":41.868556,"median":74.543389,"eighty":124.324942,"marketCap":3391402276},{"date":"2022-07-29","current":82.185457,"twenty":42.602719,"median":74.985852,"eighty":124.324942,"marketCap":3564794194},{"date":"2022-08-05","current":82.291899,"twenty":43.849716,"median":75.3419,"eighty":124.324942,"marketCap":3569411138},{"date":"2022-08-12","current":56.977427,"twenty":44.747815,"median":75.512988,"eighty":124.324942,"marketCap":3857713676},{"date":"2022-08-19","current":57.936321,"twenty":45.53495,"median":75.512988,"eighty":124.324942,"marketCap":3922636546},{"date":"2022-08-26","current":56.94343,"twenty":46.060774,"median":75.512988,"eighty":124.324942,"marketCap":3855411875},{"date":"2022-09-02","current":55.889905,"twenty":46.344767,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-09","current":58.262232,"twenty":46.74555,"median":75.512988,"eighty":124.324942,"marketCap":3944702660},{"date":"2022-09-16","current":58.186439,"twenty":47.088487,"median":75.512988,"eighty":124.324942,"marketCap":3939571006},{"date":"2022-09-23","current":55.889905,"twenty":47.296251,"median":75.512988,"eighty":124.324942,"marketCap":3784081880},{"date":"2022-09-30","current":56.109705,"twenty":47.555234,"median":75.512988,"eighty":124.324942,"marketCap":3798963678},{"date":"2022-10-07","current":57.557355,"twenty":48.010942,"median":75.512988,"eighty":124.324942,"marketCap":3896978275},{"date":"2022-10-14","current":58.012114,"twenty":48.76538,"median":75.512988,"eighty":124.324942,"marketCap":3927768201},{"date":"2022-10-21","current":60.649717,"twenty":49.274711,"median":75.512988,"eighty":124.324942,"marketCap":4106349770},{"date":"2022-10-28","current":63.272162,"twenty":49.733238,"median":75.512988,"eighty":124.324942,"marketCap":4283905009},{"date":"2022-11-04","current":61.134794,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4139192358},{"date":"2022-11-11","current":46.610721,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4010712688},{"date":"2022-11-18","current":47.010661,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4045126374},{"date":"2022-11-25","current":49.145638,"twenty":50.311585,"median":75.512988,"eighty":124.324942,"marketCap":4228834728},{"date":"2022-12-02","current":50.66306,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4359404302},{"date":"2022-12-09","current":47.134172,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4055754130},{"date":"2022-12-16","current":46.069625,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3964152995},{"date":"2022-12-23","current":46.56955,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":4007170103},{"date":"2022-12-30","current":46.257832,"twenty":50.532751,"median":75.512988,"eighty":124.324942,"marketCap":3980347671},{"date":"2023-01-06","current":43.287685,"twenty":50.066658,"median":75.178327,"eighty":123.589501,"marketCap":3724775443},{"date":"2023-01-13","current":50.410156,"twenty":49.925919,"median":74.62356,"eighty":121.823547,"marketCap":4337642707},{"date":"2023-01-20","current":52.53337,"twenty":49.925919,"median":74.252899,"eighty":117.448306,"marketCap":4520338893},{"date":"2023-01-27","current":50.098438,"twenty":49.925919,"median":73.400375,"eighty":115.406743,"marketCap":4310820275},{"date":"2023-02-03","current":51.245326,"twenty":49.800935,"median":72.34781,"eighty":114.777933,"marketCap":4409506581},{"date":"2023-02-10","current":42.450958,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4065061322},{"date":"2023-02-17","current":42.819731,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4100374588},{"date":"2023-02-24","current":41.565905,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3980309485},{"date":"2023-03-03","current":41.091769,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3934906716},{"date":"2023-03-10","current":39.695703,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3801220782},{"date":"2023-03-17","current":40.359493,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3864784660},{"date":"2023-03-24","current":40.786215,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":3905647153},{"date":"2023-03-31","current":43.594152,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4174532445},{"date":"2023-04-06","current":44.431792,"twenty":49.766923,"median":72.183716,"eighty":114.652068,"marketCap":4254744005},{"date":"2023-04-14","current":45.048169,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4313767606},{"date":"2023-04-21","current":44.268479,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4239105273},{"date":"2023-04-28","current":43.615225,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4176550346},{"date":"2023-05-05","current":42.587931,"twenty":49.800935,"median":72.216125,"eighty":114.674627,"marketCap":4078177678},{"date":"2023-05-12","current":37.524937,"twenty":49.634964,"median":72.006752,"eighty":114.674627,"marketCap":4330415288},{"date":"2023-05-19","current":36.432063,"twenty":49.470785,"median":71.609259,"eighty":114.674627,"marketCap":4204296483},{"date":"2023-05-26","current":36.297944,"twenty":49.138253,"median":70.90224,"eighty":114.674627,"marketCap":4188819017},{"date":"2023-06-02","current":37.914008,"twenty":48.900494,"median":70.079794,"eighty":114.674627,"marketCap":4375314458},{"date":"2023-06-09","current":38.684814,"twenty":48.81157,"median":69.523462,"eighty":114.697185,"marketCap":4464266214},{"date":"2023-06-16","current":36.5432,"twenty":48.359383,"median":68.782359,"eighty":114.697185,"marketCap":4217121848},{"date":"2023-06-23","current":37.41357,"twenty":48.034039,"median":67.855084,"eighty":114.719744,"marketCap":4317563349},{"date":"2023-06-30","current":37.198726,"twenty":47.795111,"median":67.0792,"eighty":114.742302,"marketCap":4292770122},{"date":"2023-07-07","current":36.199043,"twenty":47.513839,"median":65.87122,"eighty":114.742302,"marketCap":4177405720},{"date":"2023-07-14","current":37.571414,"twenty":47.13704,"median":65.431477,"eighty":114.742302,"marketCap":4335778781},{"date":"2023-07-21","current":40.517848,"twenty":47.09989,"median":65.085875,"eighty":114.742302,"marketCap":4675800177},{"date":"2023-07-28","current":40.991382,"twenty":46.893622,"median":64.463228,"eighty":114.62951,"marketCap":4730446472},{"date":"2023-08-04","current":40.180236,"twenty":46.640128,"median":63.848761,"eighty":114.62951,"marketCap":4636839392},{"date":"2023-08-11","current":33.780528,"twenty":46.453003,"median":63.523476,"eighty":114.197827,"marketCap":4613271549},{"date":"2023-08-18","current":32.135505,"twenty":46.303836,"median":63.329166,"eighty":113.741296,"marketCap":4388617345},{"date":"2023-08-25","current":32.090944,"twenty":46.104914,"median":62.994775,"eighty":112.790968,"marketCap":4382531904},{"date":"2023-09-01","current":33.32007,"twenty":45.899062,"median":62.338276,"eighty":111.980393,"marketCap":4550388657},{"date":"2023-09-08","current":32.644236,"twenty":45.588443,"median":61.963237,"eighty":111.151185,"marketCap":4458092799},{"date":"2023-09-15","current":33.442611,"twenty":45.332649,"median":61.591282,"eighty":108.66356,"marketCap":4567123620},{"date":"2023-09-22","current":33.453751,"twenty":45.027096,"median":61.359457,"eighty":104.4523,"marketCap":4568644980},{"date":"2023-09-29","current":33.851082,"twenty":44.674128,"median":61.088808,"eighty":100.62634,"marketCap":4622906831},{"date":"2023-10-06","current":32.506842,"twenty":44.409226,"median":60.907196,"eighty":99.38139,"marketCap":4439329355},{"date":"2023-10-13","current":32.562542,"twenty":44.268479,"median":60.628899,"eighty":98.805587,"marketCap":4446936156},{"date":"2023-10-20","current":33.568866,"twenty":43.94712,"median":60.337322,"eighty":98.141199,"marketCap":4584365704},{"date":"2023-10-27","current":31.025207,"twenty":43.721642,"median":60.270751,"eighty":97.618547,"marketCap":4236988435},{"date":"2023-11-03","current":33.805375,"twenty":43.615225,"median":59.995745,"eighty":97.24472,"marketCap":4336452084},{"date":"2023-11-10","current":33.852843,"twenty":43.397999,"median":59.590266,"eighty":96.788062,"marketCap":4342541181},{"date":"2023-11-17","current":35.292717,"twenty":43.09473,"median":59.300599,"eighty":96.510871,"marketCap":4527243797},{"date":"2023-11-24","current":32.41297,"twenty":42.882949,"median":59.047612,"eighty":96.179039,"marketCap":4157838565},{"date":"2023-12-01","current":31.989711,"twenty":42.721248,"median":58.920552,"eighty":96.025608,"marketCap":4103544114},{"date":"2023-12-08","current":32.935122,"twenty":42.386415,"median":58.853577,"eighty":95.310906,"marketCap":4224818635},{"date":"2023-12-15","current":35.110755,"twenty":42.308016,"median":58.70523,"eighty":94.9012,"marketCap":4503902258},{"date":"2023-12-22","current":33.821198,"twenty":41.984872,"median":58.322866,"eighty":94.533572,"marketCap":4338481783},{"date":"2023-12-29","current":34.378951,"twenty":41.734279,"median":58.224335,"eighty":94.358582,"marketCap":4410028676},{"date":"2024-01-05","current":32.361546,"twenty":41.565905,"median":58.012114,"eighty":94.027739,"marketCap":4151242043},{"date":"2024-01-12","current":32.765027,"twenty":41.050004,"median":57.901951,"eighty":93.689799,"marketCap":4202999369},{"date":"2024-01-19","current":33.030059,"twenty":40.916657,"median":57.809931,"eighty":92.879374,"marketCap":4236996829},{"date":"2024-01-26","current":32.132116,"twenty":40.786215,"median":57.557355,"eighty":92.217147,"marketCap":4121811406},{"date":"2024-02-02","current":30.854426,"twenty":40.645981,"median":57.415067,"eighty":91.542793,"marketCap":3957913206},{"date":"2024-02-09","current":31.340588,"twenty":40.530546,"median":57.27692,"eighty":90.845062,"marketCap":3966903598},{"date":"2024-02-16","current":28.840884,"twenty":40.391805,"median":57.021432,"eighty":90.511809,"marketCap":3650506089},{"date":"2024-02-23","current":30.052619,"twenty":40.28554,"median":56.959244,"eighty":90.267746,"marketCap":3803880163},{"date":"2024-03-01","current":29.282245,"twenty":40.169713,"median":56.86082,"eighty":89.975454,"marketCap":3706370818},{"date":"2024-03-08","current":31.196143,"twenty":39.686358,"median":56.779913,"eighty":89.650338,"marketCap":3948620596},{"date":"2024-03-15","current":30.333484,"twenty":39.199647,"median":56.623635,"eighty":89.309009,"marketCap":3839430445},{"date":"2024-03-22","current":32.215284,"twenty":38.802962,"median":56.576565,"eighty":89.042645,"marketCap":4077617333},{"date":"2024-03-28","current":33.739983,"twenty":38.68383,"median":56.517971,"eighty":88.628965,"marketCap":4270604578},{"date":"2024-04-05","current":34.060972,"twenty":38.430798,"median":56.447391,"eighty":88.026299,"marketCap":4311233472},{"date":"2024-04-12","current":34.714988,"twenty":38.170539,"median":56.213034,"eighty":87.780769,"marketCap":4394014842},{"date":"2024-04-19","current":33.487204,"twenty":37.914008,"median":56.109705,"eighty":87.462688,"marketCap":4238609324},{"date":"2024-04-26","current":35.172397,"twenty":37.610343,"median":55.996257,"eighty":87.410344,"marketCap":4451911016},{"date":"2024-05-03","current":37.447409,"twenty":37.448115,"median":55.925691,"eighty":87.031236,"marketCap":4739868299},{"date":"2024-05-10","current":40.004036,"twenty":37.42173,"median":55.823822,"eighty":86.74189,"marketCap":4702794434},{"date":"2024-05-17","current":40.954456,"twenty":37.42173,"median":55.726494,"eighty":86.304612,"marketCap":4814523891},{"date":"2024-05-24","current":38.334996,"twenty":37.42173,"median":55.579945,"eighty":86.083348,"marketCap":4506585418},{"date":"2024-05-31","current":36.609402,"twenty":37.413918,"median":55.43486,"eighty":85.929862,"marketCap":4303728065},{"date":"2024-06-07","current":37.873064,"twenty":37.403047,"median":55.250346,"eighty":85.523848,"marketCap":4452281703},{"date":"2024-06-14","current":37.296603,"twenty":37.244592,"median":55.138245,"eighty":85.094818,"marketCap":4384514082},{"date":"2024-06-21","current":37.058217,"twenty":37.126478,"median":55.022209,"eighty":84.728755,"marketCap":4356489879},{"date":"2024-06-28","current":36.052661,"twenty":37.09896,"median":54.946314,"eighty":83.535921,"marketCap":4238278691},{"date":"2024-07-05","current":36.464419,"twenty":37.043719,"median":54.885353,"eighty":82.319567,"marketCap":4286684134},{"date":"2024-07-12","current":38.791935,"twenty":37.017445,"median":54.609,"eighty":81.867773,"marketCap":4560302271},{"date":"2024-07-15","current":39.260039,"twenty":37.017445,"median":54.589123,"eighty":81.773605,"marketCap":4615331616},{"date":"2024-08-02","current":39.064995,"twenty":36.955248,"median":54.288688,"eighty":80.360332,"marketCap":4592402722},{"date":"2024-08-09","current":34.046029,"twenty":36.92102,"median":54.107954,"eighty":79.911493,"marketCap":3911514209},{"date":"2024-08-16","current":32.959122,"twenty":36.827919,"median":53.974996,"eighty":79.219819,"marketCap":3786640538},{"date":"2024-08-23","current":33.631757,"twenty":36.777806,"median":53.857029,"eighty":78.263641,"marketCap":3863918917},{"date":"2024-08-30","current":33.578302,"twenty":36.705542,"median":53.663055,"eighty":77.612662,"marketCap":3857777588},{"date":"2024-09-06","current":33.221939,"twenty":36.5432,"median":53.423229,"eighty":77.092502,"marketCap":3816835401},{"date":"2024-09-13","current":32.633941,"twenty":36.479103,"median":53.275733,"eighty":76.801829,"marketCap":3749280792},{"date":"2024-09-20","current":33.444666,"twenty":36.348592,"median":52.83765,"eighty":76.249976,"marketCap":3842424268},{"date":"2024-09-27","current":34.099483,"twenty":36.143985,"median":52.576392,"eighty":75.985907,"marketCap":3917655537},{"date":"2024-10-04","current":34.781028,"twenty":35.815644,"median":52.005614,"eighty":75.653859,"marketCap":3995957470},{"date":"2024-10-11","current":33.16403,"twenty":35.398884,"median":51.644579,"eighty":75.347255,"marketCap":3810182296},{"date":"2024-10-18","current":33.827757,"twenty":35.286388,"median":51.321786,"eighty":74.99485,"marketCap":3886437119},{"date":"2024-10-25","current":33.769848,"twenty":35.073467,"median":50.961335,"eighty":74.557795,"marketCap":3879784014},{"date":"2024-10-31","current":32.081578,"twenty":34.946551,"median":50.677905,"eighty":73.643703,"marketCap":3685820402},{"date":"2024-11-08","current":35.100579,"twenty":34.791083,"median":50.174897,"eighty":72.654053,"marketCap":4345872942},{"date":"2024-11-15","current":36.812407,"twenty":34.791083,"median":50.02786,"eighty":72.052383,"marketCap":4557817745},{"date":"2024-11-22","current":34.654368,"twenty":34.70383,"median":49.822008,"eighty":71.813687,"marketCap":4290626666},{"date":"2024-11-29","current":35.481887,"twenty":34.699053,"median":49.663186,"eighty":71.167911,"marketCap":4393083395},{"date":"2024-12-06","current":32.723492,"twenty":34.589092,"median":49.471895,"eighty":70.134049,"marketCap":4051560964},{"date":"2024-12-13","current":33.384695,"twenty":34.425584,"median":49.145638,"eighty":69.703258,"marketCap":4133425900},{"date":"2024-12-20","current":31.194205,"twenty":34.307596,"median":48.886853,"eighty":69.013231,"marketCap":3862216910},{"date":"2024-12-27","current":31.985215,"twenty":34.216342,"median":48.780986,"eighty":68.150231,"marketCap":3960153489},{"date":"2025-01-03","current":31.802675,"twenty":34.159174,"median":48.421341,"eighty":67.685601,"marketCap":3937552740},{"date":"2025-01-10","current":31.680981,"twenty":34.09592,"median":48.051683,"eighty":66.243612,"marketCap":3922485574},{"date":"2025-01-17","current":29.827177,"twenty":34.062068,"median":47.691624,"eighty":65.473912,"marketCap":3692962411},{"date":"2025-01-24","current":29.555394,"twenty":34.038606,"median":47.505878,"eighty":65.235863,"marketCap":3659312406},{"date":"2025-01-31","current":28.180253,"twenty":33.968145,"median":47.135606,"eighty":64.762279,"marketCap":3489053429},{"date":"2025-02-07","current":24.323243,"twenty":33.900182,"median":47.085636,"eighty":64.253801,"marketCap":3163602642},{"date":"2025-02-14","current":24.059445,"twenty":33.848111,"median":46.893327,"eighty":63.64383,"marketCap":3129291757},{"date":"2025-02-21","current":24.507494,"twenty":33.805614,"median":46.748088,"eighty":63.36814,"marketCap":3187567217},{"date":"2025-02-28","current":24.940093,"twenty":33.751655,"median":46.4766,"eighty":63.305096,"marketCap":3243833179},{"date":"2025-03-07","current":25.955928,"twenty":33.698834,"median":46.303836,"eighty":62.823315,"marketCap":3375957715},{"date":"2025-03-14","current":25.465391,"twenty":33.671773,"median":46.104914,"eighty":62.370223,"marketCap":3312156133},{"date":"2025-03-21","current":24.812631,"twenty":33.631757,"median":45.899062,"eighty":62.370223,"marketCap":3227254815},{"date":"2025-03-28","current":24.801043,"twenty":33.568866,"median":45.463832,"eighty":62.195899,"marketCap":3225747691},{"date":"2025-04-04","current":24.032408,"twenty":33.538212,"median":45.269432,"eighty":61.915464,"marketCap":3125775134},{"date":"2025-04-11","current":22.892974,"twenty":33.466383,"median":44.987585,"eighty":61.454392,"marketCap":2977574609},{"date":"2025-04-17","current":21.973701,"twenty":33.444666,"median":44.72681,"eighty":61.359919,"marketCap":2858009440},{"date":"2025-04-25","current":23.916533,"twenty":33.40903,"median":44.409226,"eighty":61.030153,"marketCap":3110703894},{"date":"2025-05-02","current":24.32982,"twenty":33.384695,"median":44.268479,"eighty":60.816466,"marketCap":3164457983},{"date":"2025-05-09","current":20.376136,"twenty":33.333303,"median":43.94712,"eighty":60.601496,"marketCap":3416650062},{"date":"2025-05-16","current":20.786595,"twenty":33.275509,"median":43.647294,"eighty":60.274332,"marketCap":3485475391},{"date":"2025-05-23","current":18.953642,"twenty":33.212021,"median":43.594152,"eighty":59.995745,"marketCap":3178127655},{"date":"2025-05-30","current":19.434931,"twenty":33.136862,"median":43.372889,"eighty":59.590266,"marketCap":3258829808},{"date":"2025-06-06","current":20.168325,"twenty":32.994758,"median":43.019921,"eighty":59.300599,"marketCap":3381804518},{"date":"2025-06-13","current":20.445148,"twenty":32.935122,"median":42.794357,"eighty":59.05806,"marketCap":3428222030},{"date":"2025-06-20","current":20.072689,"twenty":32.903454,"median":42.519444,"eighty":59.049702,"marketCap":3365768433},{"date":"2025-06-27","current":21.422138,"twenty":32.826351,"median":42.358765,"eighty":59.049702,"marketCap":3592042617},{"date":"2025-07-03","current":22.023803,"twenty":32.763412,"median":42.270964,"eighty":58.94778,"marketCap":3692929196},{"date":"2025-07-11","current":22.396262,"twenty":32.712177,"median":41.885191,"eighty":58.897162,"marketCap":3755382792},{"date":"2025-07-18","current":21.043948,"twenty":32.632287,"median":41.685812,"eighty":58.848934,"marketCap":3528628196},{"date":"2025-07-25","current":21.276019,"twenty":32.589701,"median":41.358335,"eighty":58.426416,"marketCap":3567541591},{"date":"2025-08-01","current":21.212987,"twenty":32.472243,"median":41.070887,"eighty":58.27739,"marketCap":3556972521},{"date":"2025-08-08","current":16.408412,"twenty":32.409946,"median":40.980992,"eighty":58.27739,"marketCap":2680100751},{"date":"2025-08-15","current":15.435056,"twenty":32.344141,"median":40.890107,"eighty":58.27739,"marketCap":2521115806},{"date":"2025-08-22","current":15.921734,"twenty":32.211263,"median":40.754606,"eighty":58.27739,"marketCap":2600608278},{"date":"2025-08-29","current":16.027918,"twenty":32.134827,"median":40.594873,"eighty":58.27739,"marketCap":2617952091},{"date":"2025-09-05","current":15.95123,"twenty":32.079623,"median":40.522806,"eighty":58.27739,"marketCap":2605426004},{"date":"2025-09-12","current":15.774256,"twenty":31.977432,"median":40.367395,"eighty":58.27739,"marketCap":2576519650},{"date":"2025-09-19","current":15.087008,"twenty":31.856603,"median":40.217505,"eighty":58.27739,"marketCap":2464266644},{"date":"2025-09-26","current":14.060561,"twenty":31.724738,"median":40.042158,"eighty":58.27739,"marketCap":2296609793},{"date":"2025-10-03","current":14.423357,"twenty":31.641523,"median":39.354745,"eighty":58.27739,"marketCap":2355867818},{"date":"2025-10-10","current":14.792052,"twenty":31.524009,"median":39.084022,"eighty":58.27739,"marketCap":2416089388},{"date":"2025-10-17","current":14.679969,"twenty":31.400177,"median":38.952863,"eighty":58.27739,"marketCap":2397782031},{"date":"2025-10-24","current":15.145999,"twenty":31.175545,"median":38.703439,"eighty":58.27739,"marketCap":2473902095},{"date":"2025-10-31","current":14.744859,"twenty":31.002719,"median":38.556255,"eighty":58.27739,"marketCap":2408381027},{"date":"2025-11-07","current":18.677669,"twenty":30.681757,"median":38.355513,"eighty":58.27739,"marketCap":3141397087},{"date":"2025-11-14","current":20.570205,"twenty":30.436951,"median":38.210341,"eighty":58.27739,"marketCap":3459702857},{"date":"2025-11-21","current":20.906966,"twenty":30.050212,"median":38.028724,"eighty":58.27739,"marketCap":3516342560},{"date":"2025-11-28","current":22.640863,"twenty":29.969216,"median":37.896633,"eighty":58.27739,"marketCap":3807966817},{"date":"2025-12-05","current":23.325516,"twenty":29.797432,"median":37.799918,"eighty":58.27739,"marketCap":3923118610},{"date":"2025-12-12","current":23.503638,"twenty":29.475641,"median":37.58676,"eighty":58.27739,"marketCap":3953076800},{"date":"2025-12-19","current":22.237308,"twenty":29.010488,"median":37.449174,"eighty":58.27739,"marketCap":3740092792},{"date":"2025-12-26","current":22.267922,"twenty":28.82644,"median":37.406993,"eighty":58.27739,"marketCap":3745241856},{"date":"2026-01-02","current":22.306886,"twenty":28.645081,"median":37.32911,"eighty":58.27739,"marketCap":3751795210},{"date":"2026-01-09","current":23.389529,"twenty":28.037331,"median":37.212455,"eighty":58.046979,"marketCap":3933884834},{"date":"2026-01-16","current":20.595254,"twenty":26.82467,"median":37.10156,"eighty":57.831411,"marketCap":3463915728},{"date":"2026-01-23","current":19.487563,"twenty":26.554284,"median":37.063484,"eighty":57.598283,"marketCap":3277613233},{"date":"2026-01-30","current":18.357607,"twenty":26.158475,"median":36.994993,"eighty":57.554081,"marketCap":3087565965},{"date":"2026-02-06","current":17.223188,"twenty":25.487021,"median":36.865307,"eighty":57.309926,"marketCap":3021567177},{"date":"2026-02-13","current":15.268295,"twenty":25.290807,"median":36.812645,"eighty":56.950229,"marketCap":2678608614},{"date":"2026-02-20","current":16.070914,"twenty":25.0691,"median":36.777806,"eighty":56.728357,"marketCap":2819416804},{"date":"2026-02-27","current":16.486792,"twenty":24.816493,"median":36.703641,"eighty":56.554757,"marketCap":2892376824},{"date":"2026-03-06","current":17.013924,"twenty":24.732291,"median":36.525858,"eighty":56.498586,"marketCap":2984854810},{"date":"2026-03-13","current":15.758343,"twenty":24.555389,"median":36.464419,"eighty":56.498586,"marketCap":2764580611},{"date":"2026-03-20","current":15.602057,"twenty":24.34835,"median":36.312545,"eighty":56.425004,"marketCap":2737162515},{"date":"2026-03-27","current":14.706727,"twenty":24.310168,"median":36.137833,"eighty":56.425004,"marketCap":2580089352},{"date":"2026-04-02","current":14.897448,"twenty":24.126653,"median":35.870547,"eighty":56.425004,"marketCap":2613548724},{"date":"2026-04-10","current":15.47491,"twenty":23.751991,"median":35.747799,"eighty":56.425004,"marketCap":2714856267},{"date":"2026-04-17","current":15.922575,"twenty":23.415614,"median":35.47792,"eighty":56.425004,"marketCap":2793392848},{"date":"2026-04-24","current":15.792778,"twenty":23.292299,"median":35.47792,"eighty":56.425004,"marketCap":2770621887},{"date":"2026-05-01","current":15.917277,"twenty":23.069468,"median":35.47792,"eighty":56.425004,"marketCap":2792463421},{"date":"2026-05-08","current":25.965463,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2526647299},{"date":"2026-05-15","current":27.27878,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2654443512},{"date":"2026-05-22","current":28.927983,"twenty":22.884856,"median":35.47792,"eighty":56.425004,"marketCap":2814924187},{"date":"2026-05-29","current":31.309848,"twenty":22.876737,"median":35.424832,"eighty":56.44471,"marketCap":3046698700},{"date":"2026-06-05","current":32.622209,"twenty":22.884856,"median":35.310518,"eighty":56.425004,"marketCap":3174401912},{"date":"2026-06-12","current":37.287862,"twenty":22.884856,"median":35.233869,"eighty":56.425004,"marketCap":3628407282},{"date":"2026-06-18","current":33.967262,"twenty":22.884856,"median":35.141576,"eighty":56.425004,"marketCap":3305286343},{"date":"2026-06-26","current":36.25105,"twenty":22.876737,"median":34.980217,"eighty":56.44471,"marketCap":3527517200},{"date":"2026-07-02","current":34.957371,"twenty":22.876737,"median":34.971382,"eighty":56.44471,"marketCap":3401631827},{"date":"2026-07-10","current":35.027426,"twenty":22.876737,"median":34.957371,"eighty":56.44471,"marketCap":3408448725},{"date":"2026-07-17","current":36.662039,"twenty":22.876737,"median":34.956482,"eighty":56.44471,"marketCap":3567509665},{"date":"2026-07-24","current":36.148303,"twenty":22.876737,"median":34.956482,"eighty":56.44471,"marketCap":3517519084},{"date":"2026-07-31","current":39.613683,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":3854728278},{"date":"2026-08-07","current":40.173225,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":3868159276},{"date":"2026-08-14","current":42.705905,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4112023469},{"date":"2026-08-21","current":51.135572,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4923690859},{"date":"2026-08-28","current":49.614074,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4777190355},{"date":"2026-09-04","current":48.598167,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4679371695},{"date":"2026-09-11","current":47.752365,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4597931974},{"date":"2026-09-17","current":50.199993,"twenty":22.868619,"median":34.944069,"eighty":56.464417,"marketCap":4833606698}],"updateTime":1789768525458},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HAE\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629817059","title":"Haemonetics study shows VASCADE MVP XL outperforms VASCADE MVP in large-bore venous closure","url":"https://stock-news.laohu8.com/highlight/detail?id=2629817059","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629817059?lang=en_us&edition=fundamental","pubTime":"2026-04-24 18:20","pubTimestamp":1777026030,"startTime":"0","endTime":"0","summary":"Haemonetics reported publication of a new single-center study comparing VASCADE MVP XL with VASCADE MVP for large-bore venous access closure in electrophysiology procedures.Study results were already published earlier this week in Journal of Cardiovascular Electrophysiology.Findings showed VASCADE MVP XL delivered stronger overall performance, with reliable hemostasis and no bleeding complications reported.Haemonetics highlighted FDA label expansion in March 2026 that positions VASCADE MVP XL for larger-sheath use in fast-growing atrial fibrillation ablation, including pulsed field ablation, as well as left atrial appendage closure procedures.Additional clinical data will be presented at Heart Rhythm 2026 on April 25, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL5vMwVq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLDYK493.USD","LU0205194284.USD","IE0034390439.USD","LU0106261612.USD","LU0012050646.USD","IE00B19Z6F94.USD","LU1169589451.USD","LU0205193047.USD","HAE","IE00B64QTZ34.USD","LU1169590202.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859117","title":"GVS FY25 net profit drops to EUR 18.4 million; revenue slips to EUR 424.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859117","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859117?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:26","pubTimestamp":1776961598,"startTime":"0","endTime":"0","summary":"GVS posted FY2025 net profit of EUR 18.4 million, down 44.8%.Adjusted EBITDA rose 3% to EUR 107 million, lifting margin 0.9 percentage point to 25.2%.Net financial indebtedness widened to EUR 240.1 million from EUR 219.8 million, mainly due to the Haemonetics whole blood acquisition.GVS said it completed closure of Puerto Rico plant, started up new sites in Lancaster and Suzhou, and expects to progressively bring major industrial production for the new Transfusion Medicine division in-house from 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GVS S.p.A. published the original content used to generate this news brief on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL5x2HFd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0205193047.USD","BK4198","IE00BLDYK493.USD","LU0205194284.USD","HAE","IE00B64QTZ34.USD","LU1169589451.USD","IE00B19Z6F94.USD","LU0012050646.USD","IE0034390439.USD","LU0106261612.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628274298","title":"Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2628274298","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628274298?lang=en_us&edition=fundamental","pubTime":"2026-04-20 18:50","pubTimestamp":1776682200,"startTime":"0","endTime":"0","summary":"ZUG, Switzerland, April  20, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276834/0/en/Evidence-Supporting-Combined-Use-of-Deucrictibant-IR-with-Deucrictibant-XR-Presented-at-CIIC-Spring-2026-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0256863902.USD","LU0012050646.USD","BK4198","IE00B64QTZ34.USD","LU0205193047.USD","LU1978683503.SGD","BK4161","LU1169590202.USD","IE00BLDYK493.USD","LU0417517546.SGD","LU0256863811.USD","IR","HAE","BK4585","IE00B19Z6F94.USD","IE0034390439.USD","LU1169589451.USD","SG9999001440.SGD","LU0205194284.USD","LU0124384867.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627232205","title":"Pharvaris: Deucrictibant Data, Strengthened HAE Pipeline, and Extended Cash Runway Support Higher $52 DCF-Based Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2627232205","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627232205?lang=en_us&edition=fundamental","pubTime":"2026-04-16 03:15","pubTimestamp":1776280523,"startTime":"0","endTime":"0","summary":"Analyst Debanjana Chatterjee of JonesTrading reiterated a Buy rating on Pharvaris, with a price target of $52.00. Debanjana Chatterjee has given hi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pharvaris-deucrictibant-data-strengthened-hae-pipeline-and-extended-cash-runway-support-higher-52-dcf-based-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pharvaris-deucrictibant-data-strengthened-hae-pipeline-and-extended-cash-runway-support-higher-52-dcf-based-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627743704","title":"BTIG Reaffirms Their Buy Rating on Haemonetics (HAE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627743704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627743704?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:37","pubTimestamp":1776080263,"startTime":"0","endTime":"0","summary":"BTIG analyst Marie Thibault maintained a Buy rating on Haemonetics today and set a price target of $84.00. Thibault covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-haemonetics-hae-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-haemonetics-hae-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625957851","title":"Ionis Extends Donidalorsen Into Children: What the New HAE Trial Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2625957851","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625957851?lang=en_us&edition=fundamental","pubTime":"2026-04-08 00:31","pubTimestamp":1775579483,"startTime":"0","endTime":"0","summary":"Ionis Pharmaceuticals Inc. ($IONS) announced an update on their ongoing clinical study. Ionis Expands Pediatric Trial of Donidalorsen in Hereditary...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ionis-extends-donidalorsen-into-children-what-the-new-hae-trial-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ionis-extends-donidalorsen-into-children-what-the-new-hae-trial-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4198","IE00BLDYK493.USD","IE00B19Z6F94.USD","LU0205193047.USD","BK4211","LU1169589451.USD","HAE","LU0012050646.USD","LU1169590202.USD","LU0205194284.USD","IE00B64QTZ34.USD","IE0034390439.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625325259","title":"Haemonetics price target lowered to $64 from $70 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2625325259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625325259?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:01","pubTimestamp":1775559664,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch lowered the firm’s price target on Haemonetics (HAE) to $64 from $70 and keeps a Neutral rating on the shares. The firm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/haemonetics-price-target-lowered-to-64-from-70-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/haemonetics-price-target-lowered-to-64-from-70-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625677137","title":"Orchestra BioMed presentation highlights pivotal trials for hypertension pacing, sirolimus artery therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2625677137","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625677137?lang=en_us&edition=fundamental","pubTime":"2026-04-06 22:59","pubTimestamp":1775487592,"startTime":"0","endTime":"0","summary":"Orchestra BioMed outlined two pivotal-stage cardiovascular programs, AVIM Therapy for uncontrolled hypertension in pacemaker-indicated patients and Virtue SAB for atherosclerotic artery disease.AVIM Therapy BACKBEAT global pivotal trial is actively enrolling up to 500 patients across about 130 sites, with primary efficacy endpoint based on change in mean 24-hour ambulatory systolic blood pressure at 3 months.Virtue SAB U.S. pivotal Virtue Trial is actively enrolling 740 coronary in-stent restenosis patients in a 1:1 randomized study versus Boston Scientific AGENT paclitaxel-coated balloon, with primary endpoint target lesion failure at 12 months.Orchestra BioMed cited cash runway into Q4 2027, with $35 million in committed tranche payments from Medtronic and Ligand and up to $21 million expected from Haemonetics acquisition of Vivasure Medical.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL43xDhr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BQXX3F31.USD","LU0882574055.USD","IE00B19Z6F94.USD","LU0345769128.USD","LU1061106388.HKD","LU1804176565.USD","LU0187121727.USD","LU0823416689.USD","LU2242649171.HKD","IE00B4R5TH58.HKD","LU0238689110.USD","IE00BVYPNV92.GBP","LU1989772840.SGD","LU2112291526.USD","BK4533","BK4504","LU2089284900.SGD","HAE","LU2506952097.USD","MDT","OBIO","LU0976567544.SGD","LU1720051017.SGD","IE00B64QTZ34.USD","LU2506951875.HKD","BSX","LU0353189680.USD","BK4581","LU0432979614.USD","LU1244550494.USD","IE00B42XCP33.USD","LU0314106906.USD","LU1169589451.USD","LU2491049909.HKD","LU0158827781.USD","LU0106261612.USD","LU1718418525.SGD","LU1244550221.USD","LU0158827948.USD","LU0823417737.USD","BK4588","LU0528227936.USD","LU2271345857.HKD","IE00B3T34201.USD","LU1791710400.SGD","LU0012050646.USD","LU2244417387.USD","LU0211326839.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625611930","title":"Does CHAPTER-3 Enrollment Milestone and Pipeline Progress Change The Bull Case For Pharvaris (PHVS)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625611930","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625611930?lang=en_us&edition=fundamental","pubTime":"2026-04-05 03:20","pubTimestamp":1775330422,"startTime":"0","endTime":"0","summary":"Pharvaris N.V. recently reported full-year 2025 results showing a net loss of €175.7 million, with basic and diluted loss per share from continuing operations of €2.97, while advancing its hereditary angioedema (HAE) pipeline.\nDespite deeper losses, Pharvaris completed enrollment in its CHAPTER-3 pivotal study of deucrictibant XR and stayed on track for a near-term regulatory filing for deucrictibant IR, underscoring the company’s focus on progressing multiple HAE treatment approaches.\nWe’ll...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/does-chapter-3-enrollment-milestone-and-pipeline-progress-ch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phvs/pharvaris/news/does-chapter-3-enrollment-milestone-and-pipeline-progress-ch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0205193047.USD","PHVS","BK4007","LU0012050646.USD","LU1169589451.USD","IE0034390439.USD","LU0205194284.USD","LU1169590202.USD","PRGS","HAE","BK4097","LU0106261612.USD","IE00B64QTZ34.USD","BK4198","IE00B19Z6F94.USD","IE00BLDYK493.USD","LU2065732104.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624508204","title":"Press Release: Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2624508204","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624508204?lang=en_us&edition=fundamental","pubTime":"2026-04-02 18:50","pubTimestamp":1775127000,"startTime":"0","endTime":"0","summary":"for prophylactic treatment of HAE attacks; topline data anticipated in. -- Timeline for submission of NDA dossier of deucrictibant IR for on-demand. treatment of HAE attacks remains on-track in 1H2026. \"The positive readout of our first pivotal Phase 3 study, RAPIDe-3, at the end of 2025 was a crucial moment for Pharvaris. With the momentum of this important milestone, we continue to execute in 2026 through the anticipated NDA submission of deucrictibant IR for the on-demand treatment of HAE attacks, topline data readout of CHAPTER-3, and enrollment in CREAATE,\" said Berndt Modig, Chief Executive Officer of Pharvaris. \"Across all our programs, Pharvaris remains committed to helping to improve standard of care for those living with bradykinin-mediated angioedema. In addition to potentially bringing deucrictibant to those with HAE type 1 and type 2, we hope to also address unmet needs of those with HAE with normal C1 inhibitor and acquired angioedema with C1 inhibitor deficiency. Our tea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0205193047.USD","BK4555","LU1169590202.USD","TM","HAE","BK4198","IE0034390439.USD","LU1169589451.USD","03160","LU0106261612.USD","BK4604","IE00B64QTZ34.USD","IE00B19Z6F94.USD","PHVS","LU0012050646.USD","BK4099","LU0205194284.USD","BK4585","IE00BLDYK493.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624499155","title":"Haemonetics sets earnings release, conference call for fiscal Q4, full-year results","url":"https://stock-news.laohu8.com/highlight/detail?id=2624499155","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624499155?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:06","pubTimestamp":1775074004,"startTime":"0","endTime":"0","summary":"Haemonetics scheduled fourth-quarter fiscal 2026 results release for May 7, 2026 at 6:00 am ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDLc2DJGb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0205194284.USD","LU1169589451.USD","BK4198","LU0012050646.USD","LU0106261612.USD","LU1169590202.USD","IE0034390439.USD","IE00BLDYK493.USD","HAE","IE00B19Z6F94.USD","LU0205193047.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623507329","title":"Haemonetics wins FDA label expansion for VASCADE MVP XL venous closure system","url":"https://stock-news.laohu8.com/highlight/detail?id=2623507329","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623507329?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:17","pubTimestamp":1774901832,"startTime":"0","endTime":"0","summary":"Haemonetics received FDA clearance to expand labeling for VASCADE MVP XL venous vascular closure system.Label now covers procedures using 10-14F inner diameter sheaths, up to 17F outer diameter.Expanded use targets larger sheaths used in pulsed field ablation, left atrial appendage closure for atrial fibrillation treatment.FDA decision was supported by AMBULATE EXPAND trial results showing 0% major access site closure-related complications.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL4z04Xw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLDYK493.USD","HAE","LU1169590202.USD","IE00B64QTZ34.USD","LU0106261612.USD","LU1169589451.USD","LU0205193047.USD","BK4198","LU0205194284.USD","IE00B19Z6F94.USD","IE0034390439.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623329515","title":"Haemonetics Receives FDA Approval for Expanded Labeling of the Vascade Mvp® Xl Venous Vascular Closure System","url":"https://stock-news.laohu8.com/highlight/detail?id=2623329515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623329515?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:15","pubTimestamp":1774901700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA6FLTPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1169590202.USD","BK4198","LU0012050646.USD","LU0205193047.USD","LU0106261612.USD","HAE","LU1169589451.USD","IE00BLDYK493.USD","LU0205194284.USD","IE00B19Z6F94.USD","IE0034390439.USD","IE00B64QTZ34.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622389782","title":"A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2622389782","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622389782?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:08","pubTimestamp":1774559309,"startTime":"0","endTime":"0","summary":"Recent share performance and business snapshot\nHaemonetics (HAE) shares have retreated over the past 3 months, with the price closing at $55.93 and total return showing declines over the week, month, past 3 months, year and year to date.\nThe Boston based medical technology company generates US$1.32b in revenue and US$175.44m in net income, with operations spanning plasma collection systems, hospital hemostasis analyzers, blood recovery products and vascular closure devices.\nSee our latest...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/a-look-at-haemonetics-hae-valuation-after-recent-share-price-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hae/haemonetics/news/a-look-at-haemonetics-hae-valuation-after-recent-share-price-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BLDYK493.USD","LU0012050646.USD","IE00B64QTZ34.USD","LU0205194284.USD","LU0106261612.USD","BK4198","IE0034390439.USD","IE00B19Z6F94.USD","LU1169590202.USD","LU0205193047.USD","LU1169589451.USD","HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622864413","title":"Sustained EKTERLY Uptake and Shift Toward Oral HAE Therapy Underpin Buy Rating on KalVista","url":"https://stock-news.laohu8.com/highlight/detail?id=2622864413","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622864413?lang=en_us&edition=fundamental","pubTime":"2026-03-26 23:35","pubTimestamp":1774539317,"startTime":"0","endTime":"0","summary":"In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on KalVista Pharmaceuticals, with a price target of $37.00. An...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sustained-ekterly-uptake-and-shift-toward-oral-hae-therapy-underpin-buy-rating-on-kalvista-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sustained-ekterly-uptake-and-shift-toward-oral-hae-therapy-underpin-buy-rating-on-kalvista-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HAE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622857936","title":"Italy's GVS FY revenue rises on healthcare & life sciences strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857936","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622857936?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:20","pubTimestamp":1774527632,"startTime":"0","endTime":"0","summary":"Italy's GVS FY revenue rises on healthcare & life sciences strengthOverviewItaly filtration solutions firm's FY 2025 revenue up 2% at constant FX, slight miss vs estimatesAdjusted EBITDA up 3%, slight","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nL1N40E0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLDYK493.USD","LU0205193047.USD","LU0012050646.USD","IE0034390439.USD","IE00B19Z6F94.USD","LU0106261612.USD","LU1169589451.USD","IE00B64QTZ34.USD","HAE","LU1169590202.USD","LU0205194284.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007554","title":"Here's one reason why experts think the CSL share price can rise 65%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007554","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007554?lang=en_us&edition=fundamental","pubTime":"2026-03-26 05:00","pubTimestamp":1774472400,"startTime":"0","endTime":"0","summary":"The CSL Ltd  share price has taken a dive over the last several months. As the chart below shows, it has fallen almost 50% from August 2025. But, experts think there's a chance that the ASX healthcare share could recover a lot of the lost ground.The global biotech business provides a number of healthcare products, including blood plasma-related treatments and vaccines.UBS recently released a note that outlined one of the reasons why investors can be excited by the business.The broker said that there has been a rapid uptake of CSL's Andembry since the launch in mid-2025, with more than 1,000 patients on the therapy. UBS estimates this is around 15% of patients on prophylactic treatment across the major markets where it has been approved.At a US price of around $400,000, the broker said this early momentum should underpin \"strong second-half FY26 sales and extend into FY27\".UBS suggests that its hereditary angioedema  forecasts may prove conservative, as it has allowed for competitive pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/26/heres-one-reason-why-experts-think-the-csl-share-price-can-rise-65/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/26/heres-one-reason-why-experts-think-the-csl-share-price-can-rise-65/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4534","LU1169589451.USD","CSL","BK4118","LU0106261612.USD","BK7501","BK7508","LU1169590202.USD","LU0205193047.USD","BK4585","LU1863844665.USD","LU0012050646.USD","LU3187612489.SGD","BK7511","HAE","IE0034235071.USD","SGXZ23171101.USD","BK4086","SG9999004303.SGD","IE00BLDYK493.USD","LU1829250122.USD","CSL.AU","LU0205194284.USD","LU1863844749.USD","LU0728928796.USD","BK4198","BK4588","UBS","IE0034390439.USD","IE00B64QTZ34.USD","BK7067","IE00B19Z6F94.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622027088","title":"Press Release: KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027088?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:00","pubTimestamp":1774436400,"startTime":"0","endTime":"0","summary":"$49.1 million global net product revenue of EKTERLY  for the eight months ended December 31, 2025. 1,702 patient start forms received in the US from launch through end of February, reflecting continued rapid adoption of first and only oral on-demand treatment for hereditary angioedema . EKTERLY launched in Japan by partner Kaken Pharmaceutical Co., LTD. Company to host conference call today at 8:30am ET. KalVista Pharmaceuticals, Inc. , today reported financial results for the eight months ended December 31, 2025, and provided a corporate update. As previously announced, the Company changed its fiscal year from ending April 30 of each year to ending December 31 of each year. There was an eight-month transition period from May 1, 2025 to December 31, 2025 and these results are presented within the condensed consolidated financial statements.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLDYK493.USD","LU1169589451.USD","BK4198","IE00B64QTZ34.USD","IE00B19Z6F94.USD","BK4203","KALV","BK4139","NHI","LU0205194284.USD","HAE","R","LU0012050646.USD","BK4225","BK4022","LU0106261612.USD","IE0034390439.USD","BK4232","LU1169590202.USD","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":7,"totalSize":138,"code":"91000000","status":"200"}]}}